BAL PHARMA LTD. - Board Meeting Intimation for 1)Approval Of Un-Audited Financial Results Of The Company For The Quarter Ended 31.12.2023. 2)To Consider Investing Additional Capital In Expanding Its Manufacturing Presence , Through A Green Field Project.

BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 ,inter alia, to consider and approve 1) Un-Audited Standalone and Consolidated financial results of the Company for the quarter and nine months ended 31.12.2023. 2)To consider investing additional capital in expanding its manufacturing presence , through a green field project.